Ryan Park

7PUBLICATIONS
70CO-AUTHORS
Molecular targetsPredictive and prognostic markersRadiation therapyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 29, 2026
Discovery of Tcf7 regulators with clonally-resolved CRISPR screens identifies Trim28 as a mediator of CD8 T cell differentiation in tumors.

|Jun 24, 2026
Multimodal blood based proteomic profiling reveals insights into mechanisms of immunotherapy resistance.

|May 22, 2026
Twist1 overexpression models an aggressive subtype of pancreatic ductal adenocarcinoma in vivo.

|Oct 11, 2025
Integrating systemic therapy and metastasis-directed therapy in oligometastatic hormone-sensitive prostate cancer.

Xiaolei Shi, Jarey H Wang, Brian F Chapin

|May 14, 2025
Hypofractionated, Dose-Escalated Radiation Versus Conventionally Fractionated Radiation for Localized Prostate Cancer: Long-Term Update of a Phase III, Prospective, Randomized Controlled Trial.

Comron Hassanzadeh, Deborah Kuban, Sarah Pasyar

|Feb 06, 2024
Early Immune Remodeling Steers Clinical Response to First-Line Chemoimmunotherapy in Advanced Gastric Cancer.

Minae An, Arnav Mehta, Byung Hoon Min

Pageof 2

Frequent Collaborators

3 joint publications

Arnav Mehta

2 joint publications

Chad Tang

2 joint publications

Comron J Hassanzadeh

2 joint publications

Nir Hacohen